Page 156 - FINAL PROGRAM

P-382 Type of gonadotropin does not affect either oocyte quality or follicular uid endocrine pro le during ovarian stimulation in oocyte donors
M.P. Alamá Faubel (Spain)
P-383 Effect of in vitro and in vivo acrylamide exposure on mouse oocyte
O. Cinar (Turkey)
P-384 The use of donor sperm in addition to donated oocytes after repeated implantation failure with donated oocytes does not improve live birth rates
A. Blazquez (Spain)
P-385 Time from egg retrieval to embryo transfer does not affect live birth rates in a freeze-all strategy
K. Lattes (Spain)
P-386 Concordance of vitamin D levels in the infertile couples’ partners
A. Mangiarini (Italy)
P-387 Expressions of aquaporin family in human luteinized granulosa cells and their correlations with IVF outcomes
H.J. Lee (Korea, South)
P-388 Oocyte donation from a family-member
J. Hasson (Canada)
P-389 Oocyte cryopreservation for social reasons: a two-center study of the users’ reproductive situations
G. Jou (Taiwan R.O.C.)
P-390 Lack of association between smoking habit at the time of treatment and live birth in recipients of oocyte donation cycles
P. Massart (France)
P-391 Progestin-primed ovarian stimulation in combination with clomiphene citrate in normalovulatory women undergoing IVF/ICSI treatments: a prospective randomized controlled trial
Y. Liu (China)
P-392 The role of Clomiphene Citrate (CC) co-treatment with progesterone-primed ovarian stimulation (PPOS) protocol in subfertility women with PCOS undergoing IVF treatment: a randomized controlled trial
H. Ye (China)
P-393 A randomized comparison of live birth rates following hormone replacement regimens for thawed blastocyst transfer
S. Taguchi (Japan)
P-394 Association of untreated subclinical hypothyroidism with live birth rates following in-vitro fertilisation: a cohort study
C. Venetis (Australia)
152